http://www.vivesfund.com Louvain Technology Fund Mon, 25 Mar 2013 10:20:36 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 http://www.vivesfund.com/en/blog-news/job-iteos-therapeutics-cherche-un-research-scientist/?utm_source=rss&utm_medium=rss&utm_campaign=job-iteos-therapeutics-cherche-un-research-scientist http://www.vivesfund.com/en/blog-news/job-iteos-therapeutics-cherche-un-research-scientist/#comments Mon, 25 Mar 2013 10:20:35 +0000 alexandra http://www.vivesfund.com/?p=914 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/job-iteos-therapeutics-cherche-un-research-scientist/feed/ 0 http://www.vivesfund.com/en/blog-news/en-promethera-biosciences-opens-the-french-part-of-its-clinical-trial-in-cell-therapy/?utm_source=rss&utm_medium=rss&utm_campaign=en-promethera-biosciences-opens-the-french-part-of-its-clinical-trial-in-cell-therapy http://www.vivesfund.com/en/blog-news/en-promethera-biosciences-opens-the-french-part-of-its-clinical-trial-in-cell-therapy/#comments Thu, 28 Feb 2013 14:18:23 +0000 alexandra http://www.vivesfund.com/?p=884 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/en-promethera-biosciences-opens-the-french-part-of-its-clinical-trial-in-cell-therapy/feed/ 0 http://www.vivesfund.com/en/uncategorized/nivelinvest-et-sopartec-cedent-telemis-spin-off-de-l%e2%80%99universite-catholique-de-louvain-%c2%ab-ucl-%c2%bb-et-leader-dans-l%e2%80%99imagerie-medicale-numerique-dans-le-cadre-d%e2%80%99une-ope/?utm_source=rss&utm_medium=rss&utm_campaign=nivelinvest-et-sopartec-cedent-telemis-spin-off-de-l%25e2%2580%2599universite-catholique-de-louvain-%25c2%25ab-ucl-%25c2%25bb-et-leader-dans-l%25e2%2580%2599imagerie-medicale-numerique-dans-le-cadre-d%25e2%2580%2599une-ope http://www.vivesfund.com/en/uncategorized/nivelinvest-et-sopartec-cedent-telemis-spin-off-de-l%e2%80%99universite-catholique-de-louvain-%c2%ab-ucl-%c2%bb-et-leader-dans-l%e2%80%99imagerie-medicale-numerique-dans-le-cadre-d%e2%80%99une-ope/#comments Fri, 22 Feb 2013 11:12:47 +0000 alexandra http://www.vivesfund.com/?p=872 Continue reading →

]]> http://www.vivesfund.com/en/uncategorized/nivelinvest-et-sopartec-cedent-telemis-spin-off-de-l%e2%80%99universite-catholique-de-louvain-%c2%ab-ucl-%c2%bb-et-leader-dans-l%e2%80%99imagerie-medicale-numerique-dans-le-cadre-d%e2%80%99une-ope/feed/ 0 http://www.vivesfund.com/en/blog-news/sorin-acquiert-neurotech-une-spin-off-de-l%e2%80%99ucl/?utm_source=rss&utm_medium=rss&utm_campaign=sorin-acquiert-neurotech-une-spin-off-de-l%25e2%2580%2599ucl http://www.vivesfund.com/en/blog-news/sorin-acquiert-neurotech-une-spin-off-de-l%e2%80%99ucl/#comments Fri, 22 Feb 2013 10:56:43 +0000 alexandra http://www.vivesfund.com/?p=862 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/sorin-acquiert-neurotech-une-spin-off-de-l%e2%80%99ucl/feed/ 0 http://www.vivesfund.com/en/blog-news/en-msc-software-acquires-ucl-spin-off-e-xstream/?utm_source=rss&utm_medium=rss&utm_campaign=en-msc-software-acquires-ucl-spin-off-e-xstream http://www.vivesfund.com/en/blog-news/en-msc-software-acquires-ucl-spin-off-e-xstream/#comments Fri, 22 Feb 2013 10:35:30 +0000 alexandra http://www.vivesfund.com/?p=851 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/en-msc-software-acquires-ucl-spin-off-e-xstream/feed/ 0 http://www.vivesfund.com/en/blog-news/vives-%e2%80%93-louvain-technology-fund-participe-a-la-levee-de-fonds-de-la-societe-delfmems-societe-francaise-active-dans-les-dispositifs-rf-mems/?utm_source=rss&utm_medium=rss&utm_campaign=vives-%25e2%2580%2593-louvain-technology-fund-participe-a-la-levee-de-fonds-de-la-societe-delfmems-societe-francaise-active-dans-les-dispositifs-rf-mems http://www.vivesfund.com/en/blog-news/vives-%e2%80%93-louvain-technology-fund-participe-a-la-levee-de-fonds-de-la-societe-delfmems-societe-francaise-active-dans-les-dispositifs-rf-mems/#comments Fri, 22 Feb 2013 10:12:33 +0000 alexandra http://www.vivesfund.com/?p=817 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/vives-%e2%80%93-louvain-technology-fund-participe-a-la-levee-de-fonds-de-la-societe-delfmems-societe-francaise-active-dans-les-dispositifs-rf-mems/feed/ 0 http://www.vivesfund.com/en/blog-news/sopartec-recherche-un-ceo-pour-sa-prochaine-spin-off-dans-le-secteur-de-la-therapie-cellulaire/?utm_source=rss&utm_medium=rss&utm_campaign=sopartec-recherche-un-ceo-pour-sa-prochaine-spin-off-dans-le-secteur-de-la-therapie-cellulaire http://www.vivesfund.com/en/blog-news/sopartec-recherche-un-ceo-pour-sa-prochaine-spin-off-dans-le-secteur-de-la-therapie-cellulaire/#comments Fri, 06 Jul 2012 12:49:43 +0000 alexandra http://www.vivesfund.com/?p=761 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/sopartec-recherche-un-ceo-pour-sa-prochaine-spin-off-dans-le-secteur-de-la-therapie-cellulaire/feed/ 0 http://www.vivesfund.com/en/blog-news/neurotech-s-a-annonce-le-marquage-ce-de-son-stimulateur-de-nerf-vague-adns-300-pour-le-traitement-de-lepilepsie/?utm_source=rss&utm_medium=rss&utm_campaign=neurotech-s-a-annonce-le-marquage-ce-de-son-stimulateur-de-nerf-vague-adns-300-pour-le-traitement-de-lepilepsie http://www.vivesfund.com/en/blog-news/neurotech-s-a-annonce-le-marquage-ce-de-son-stimulateur-de-nerf-vague-adns-300-pour-le-traitement-de-lepilepsie/#comments Tue, 19 Jun 2012 18:35:30 +0000 alexandra http://www.vivesfund.com/?p=744 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/neurotech-s-a-annonce-le-marquage-ce-de-son-stimulateur-de-nerf-vague-adns-300-pour-le-traitement-de-lepilepsie/feed/ 0 http://www.vivesfund.com/en/blog-news/promethera-biosciences-traite-les-premiers-patients-avec-le-produit-de-therapie-cellulaire-promethera%c2%ae-hepastem/?utm_source=rss&utm_medium=rss&utm_campaign=promethera-biosciences-traite-les-premiers-patients-avec-le-produit-de-therapie-cellulaire-promethera%25c2%25ae-hepastem http://www.vivesfund.com/en/blog-news/promethera-biosciences-traite-les-premiers-patients-avec-le-produit-de-therapie-cellulaire-promethera%c2%ae-hepastem/#comments Mon, 14 May 2012 13:36:32 +0000 admin http://www.vivesfund.com/?p=724 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/promethera-biosciences-traite-les-premiers-patients-avec-le-produit-de-therapie-cellulaire-promethera%c2%ae-hepastem/feed/ 0 http://www.vivesfund.com/en/blog-news/vives-souscrit-a-laugmentation-de-capital-de-e-6-million-de-greenwatt-pour-accompagner-sa-croissance/?utm_source=rss&utm_medium=rss&utm_campaign=vives-souscrit-a-laugmentation-de-capital-de-e-6-million-de-greenwatt-pour-accompagner-sa-croissance http://www.vivesfund.com/en/blog-news/vives-souscrit-a-laugmentation-de-capital-de-e-6-million-de-greenwatt-pour-accompagner-sa-croissance/#comments Fri, 20 Apr 2012 15:53:31 +0000 alexandra http://www.vivesfund.com/?p=671 Continue reading →

]]> http://www.vivesfund.com/en/blog-news/vives-souscrit-a-laugmentation-de-capital-de-e-6-million-de-greenwatt-pour-accompagner-sa-croissance/feed/ 0